haku: @indexterm market efficiency / yhteensä: 128
viite: 19 / 128
| Tekijä: | Jones, G. T. Hagtwedt, R. |
| Otsikko: | Marketing in Heterozygous advantage |
| Lehti: | Journal of Business Ethics
2008 : JAN I, VOL. 77:1, p. 85-97 |
| Asiasana: | bio-technology ethics marketing market efficiency |
| Kieli: | eng |
| Tiivistelmä: | This paper focuses on heterozygous advantage which is a form of human genetic engineering. First, the article presents a generalized model of the condition. Then, ethical concerns relating to the combination of heterozygous advantage and the possibility of biotechnological intervention are presented. There is a risk that perverse incentives may arise for firms marketing genetic intervention in circumstances where heterozygous advantage is possible. This misalignment with social welfare has two reasons. First, It has arisen because ill-conceived market intervention where markets are capable of achieving efficient outcomes. Secondly, there is a lack of market intervention where the markets have failed. Finally, the study offers a few proposals to address these shortcomings. |
SCIMA